Americans are living longer than ever. This is obviously good news. But that also means that an increasing number of populations are facing new challenges and struggles with respect to aging. For many, it manifests itself in the form of cognitive decline. According to the World Health Organization, dementia, Alzheimer's disease, and other cognitive states are currently the seventh leading cause of death in the world.
According to the Alzheimer's Disease Association, about one-third of all older people die of Alzheimer's disease or another type of dementia. Fortunately, however, researchers have recently discovered one thing they can do to prevent cognitive decline. It only takes 30 minutes a day.
1. A quick 30-minute walk can help cognitive function in people with mild cognitive impairment.
Researchers at the University of Texas Southwestern Medical Center have published a study in the Journal of Applied Physiology investigating the association between Alzheimer's disease and other forms of dementia and exercise. Texas scientists are interested in knowing what can be done to improve the quality of life of more than 6 million Americans who suffer from some form of dementia.
A one-year study enrolled 70 men and women between the ages of 55 and 80 with mild cognitive impairment (MCI). MCI progresses along the way to completing Alzheimer's disease. The researchers divided the participants into two groups. The first was an active walk several times a week and the second was a stretching and strengthening class without aerobic components. The first group started with training three times a week, lasting 25-30 minutes, and in seven months, the number of active walking sessions of 30-40 minutes per week increased to four-5. Studies have shown that walking groups, in addition to better cardiovascular fitness, have improved athletic performance and improved memory and cognitive function. The group had to do stretching exercises for a year, but it didn't.
"Aerobic exercise is very important for improving both vascular and brain function," Dr. Rong Zhang, a principal researcher, and professor of neurology at UT Southwestern, told Healthline. "The brain is a unique organ. It requires a constant blood flow and oxygen supply."
2. Diagnosis of dementia is also increasing among younger age groups.
We usually consider Alzheimer's disease to be a very aging disease, but even younger patients are experiencing more and more cases. According to the Alzheimer's Association, nearly 30 percent of all cases are now reported to Americans under the age of 75. According to Blue Cross Blue Shield data, early dementia, or dementia diagnosed in people between the ages of 30 and 65, has more than doubled in recent years.
Currently, 250,000 to 300,000 Americans suffer from some form of early dementia, and women form an unequal number of cases. Blue Cross Blue Shield reports that nearly 60 percent of all early cases are diagnosed in women.
3. Pay attention to cognitive health and notice these early signs of dementia. Not all memory loss is a sign of dementia, but Centers for Disease Control and Prevention (CDC) experts have some things to keep in mind if you are concerned about the possibility of diagnosing dementia. It states that there is.
If you suddenly get lost, get confused, learn common words, or have difficulty doing your daily work, you may experience the early stages of dementia. Dementia can also cause people to repeat themselves and have difficulty following stories. There are also mood swings that can be a symptom of the illness, such as indifference and depression. Talk to your doctor if you think you have dementia.
4. The FDA recently approved a new treatment for Alzheimer's disease, but some believe it simply provides false hope.
Scientists are working hard to find a cure for cognitive disorders. Earlier this summer, the US Food and Drug Administration approved a unique drug to treat the root cause of dementia aducanumab. Despite the fact that 10 out of 11 members of the FDA panel are about the drug, the FDA is Aduhelm because it is the first drug to treat the underlying cause rather than focusing on the symptoms of Alzheimer's disease. Gave or approved a "quick way" voted against. After aducanumab was approved, three members of the panel resigned, claiming to give false hope to people with Alzheimer's disease. In a resignation from the panel, Harvard Medical School Doctor Aaron Kesselheim called drug approval "probably the worst drug approval decision in American history in recent years," and Aducanumab "evidence" that it "significantly benefits." There are few. " 'People with dementia.
However, while scientists continue to debate the effectiveness of this treatment, there is no doubt that faster walking is a safe and easy way to keep your brain healthy.